Journal
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Volume 140, Issue 1, Pages 57-59Publisher
MOSBY-ELSEVIER
DOI: 10.1016/j.jaci.2017.02.018
Keywords
C3 nephritic factor; alternative complement activation; membranoproliferative glomerulonephritis; C3 glomerulopathy; dense-deposit disease; partial lipodystrophy; eculizumab
Categories
Funding
- DUET Trial
- SHIPAHOY
- NEPTUNE II
- CureGN
- National Institutes of Health
- Lupus Foundation of American
- Alliance for Lupus Research
- American Academy of Allergy, Asthma Immunology